Adrienne M Hammill
Affiliations: | Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States |
Area:
Vascular anomalies, clinical trialsWebsite:
https://www.cincinnatichildrens.org/bio/h/adrienne-hammillGoogle:
"Adrienne Hammill"Bio:
Parents
Sign in to add mentor| Denise Adams | research assistant | University of Cincinnati College of Medicine | ||
| Richard H. Scheuermann | grad student | 2001 | UT Southwestern | |
| (Asymmetric cell division results in differential apoptotic cell fates in a B-cell lymphoma model of tumor dormancy) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McDaniel CG, Adams DM, Steele KE, et al. (2023) Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment. Pediatric Blood & Cancer. e30219 |
| Engel ER, Hammill A, Adams D, et al. (2023) Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic response. Pediatric Blood & Cancer. e30215 |
| Blei F, Adams D, Brandao LR, et al. (2022) It is timely and exciting that Pediatric Blood and Cancer has endorsed a supplement dedicated to Vascular Anomalies. Pediatric Blood & Cancer. e29796 |
| Canaud G, Hammill AM, Adams D, et al. (2021) A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet Journal of Rare Diseases. 16: 306 |
| Canaud G, López Gutiérrez JC, Hammill AM, et al. (2021) EPIK-P2: A prospective phase 2, double-blind, randomized, placebo-controlled study of alpelisib in pediatric and adult patients (Pts) with PIK3CA-related overgrowth spectrum (PROS). Journal of Clinical Oncology. 39: TPS3160-TPS3160 |
| Eng W, Hammill AM, Adams DM. (2020) Overgrowth syndromes and new therapies. Seminars in Pediatric Surgery. 29: 150974 |
| Faughnan ME, Mager JJ, Hetts SW, et al. (2020) Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Annals of Internal Medicine |
| Ricci KW, Chute C, Hammill AM, et al. (2020) Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy. Pediatric Blood & Cancer. e28277 |
| Le Cras TD, Goines J, Lakes N, et al. (2020) Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation. Angiogenesis |
| Shin SM, Kim HK, Crotty EJ, et al. (2020) CT Angiography Findings of Pulmonary Arteriovenous Malformations in Children and Young Adults With Hereditary Hemorrhagic Telangiectasia. Ajr. American Journal of Roentgenology. 1-8 |